Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 17;12(17):1687-1696.
doi: 10.18632/oncotarget.28035.

Scent test using Caenorhabditis elegans to screen for early-stage pancreatic cancer

Affiliations

Scent test using Caenorhabditis elegans to screen for early-stage pancreatic cancer

Ayumu Asai et al. Oncotarget. .

Abstract

Although early detection and diagnosis are indispensable for improving the prognosis of patients with pancreatic cancer, both have yet to be achieved. Except for pancreatic cancer, other cancers have already been screened through scent tests using animals or microorganisms, including Caenorhabditis elegans. While such a method may greatly improve the prognosis of pancreatic cancer, no studies have investigated the same, mainly given the difficulty of collecting suitable samples from patients with early-stage pancreatic cancer. In this study, we organized a nationwide study group comprising high-volume centers throughout Japan to collect patients with very-early-stage pancreatic cancer (stage 0 or IA). We initially performed an open-label study involving 83 cases (stage 0-IV), with subsequent results showing significant differences after surgical removal in stage 0-IA (×10 dilution: p < 0.001; ×100 dilution: p < 0.001). Thereafter, a blinded study on 28 cases (11 patients with stage 0 or IA disease and 17 healthy volunteers) was conducted by comparing very-early-stage pancreatic cancer patients with healthy volunteers to determine whether C. elegans could detect the scent of cancer for the diagnosis of early-stage pancreatic cancer. Preoperative urine samples had a significantly higher chemotaxis index compared to postoperative samples in patients with pancreatic cancer [×10 dilution: p < 0.001, area under the receiver operating characteristic curve (AUC) = 0.845; ×100 dilution: p < 0.001, AUC = 0.820] and healthy volunteers (×10 dilution: p = 0.034; ×100 dilution: p = 0.088). Moreover, using the changes in preoperative and postoperative chemotaxis index, this method had a higher sensitivity for detecting early pancreatic cancer compared to existing diagnostic markers. The clinical application C. elegans for the early diagnosis of cancer can certainly be expected in the near future.

Keywords: Caenorhabditis elegans; biomarker; diagnosis; early-stage pancreatic cancer; scent test.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST Institutional endowments were partially received from Hirotsu Bio Science, Inc. (Tokyo, Japan); Kinshu-kai Medical Corporation (Osaka, Japan); IDEA Consultants, Inc. (Tokyo, Japan); Kyowakai Medical Corporation (Hyogo, Japan); Unitech Co., Ltd. (Chiba, Japan); Chugai Co., Ltd. (Tokyo, Japan); Yakult Honsha Co., Ltd. (Tokyo, Japan); and Ono Pharmaceutical Co., Ltd. (Osaka, Japan). N.K. and T.H. are employees of Hirotsu Bio Science, Inc.

Figures

Figure 1
Figure 1. Schema of the scent test using Caenorhabditis elegans for the screening of pancreatic cancer in the open-label study.
Figure 2
Figure 2. Scent test using Caenorhabditis elegans before and after surgical removal of pancreatic ductal adenocarcinoma.
The chemotaxis index was measured in 83 cases. The scent tests were performed in cases of all pancreatic cancers (A), stages 0/IA (B), and IB–IV (C).
Figure 3
Figure 3. Diagnostic accuracy of the scent test using Caenorhabditis elegans before and after surgical removal of pancreatic ductal adenocarcinoma.
Figure 4
Figure 4. Schema of the scent test using Caenorhabditis elegans for the screening of pancreatic cancer in the blinded study.
Figure 5
Figure 5. Scent test using Caenorhabditis elegans for the diagnosis of early pancreatic ductal adenocarcinoma.
The chemotaxis index was measured in 11 early pancreatic ductal adenocarcinoma cases and 17 healthy volunteers.

Similar articles

Cited by

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020; 70:7–30. 10.3322/caac.21590. - DOI - PubMed
    1. Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet. 2011; 378:607–20. 10.1016/S0140-6736(10)62307-0. - DOI - PMC - PubMed
    1. Fukuyama S, Mikami Y, Egawa S, Takeda K, Matsuno S. [Clinical classification and pathological physiology of acute pancreatitis]. [Article in Japanese]. Nihon Rinsho. 2004; 62:1973–76. - PubMed
    1. Egawa S, Toma H, Ohigashi H, Okusaka T, Nakao A, Hatori T, Maguchi H, Yanagisawa A, Tanaka M. Japan Pancreatic Cancer Registry; 30th year anniversary: Japan Pancreas Society. Pancreas. 2012; 41:985–92. 10.1097/MPA.0b013e318258055c. - DOI - PubMed
    1. Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, Kamiyama M, Hruban RH, Eshleman JR, Nowak MA, Velculescu VE, Kinzler KW, Vogelstein B, Iacobuzio-Donahue CA. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature. 2010; 467:1114–17. 10.1038/nature09515. - DOI - PMC - PubMed